CME-CPD

Educational objectives

After participating in this educational activity, participants should be able to:

  • Review current basic science, clinical, and translational research in pain medicine and their role in the development/use of novel analgesics, targets for interventional techniques, and applicability to clinical practice.
  • Evaluate new trends, techniques, therapies, and diagnostic procedures in pain management.
  • Discuss current research and clinical issues in the opioid epidemic that impact the practice of pain medicine.
  • Discuss how alcohol use and a variety of non-opioid analgesics may lead to complications in chronic pain patients.
  • Develop a critical and balanced interpretation of current research and proposed new research methods on mechanisms underlying challenging pain syndromes in both adult and pediatric populations in order to offer patients the best evidence-based therapies.
  • Address common clinical challenges in the management of acute and chronic pain, including those encountered in special populations.
  • Improve awareness of safe practices and understand the role of risk mitigation for patient safety in pain medicine.
  • Explore how pain medicine providers may impact the field outside of conventional clinical or research roles.
  • Discuss important practice management issues in light of the always changing landscape of pain medicine practice.
  • Recognize the value of interdisciplinary collaboration and providing comprehensive care in pain medicine.
  • Identify the importance of physician and provider safety in pain clinics and ways to improve safety for all working in pain medicine clinics.
  • Highlight the significance of wellness for both patients and physicians and explore potential personal adaptation strategies to address professional burnout and energize one’s practice.
  • Pontificate on the future of pain medicine and how the specialty is stronger when collectively striving for equality, inclusivity, and strength in the engagement of all disciplines involved in the progress of pain medicine.
  • Thoughtfully engage and assemble a valuable network of diverse colleagues active in the field of pain medicine.

Target audience

The ASRA CME program provides educational activities to physicians, residents, fellows, and scientists.  ASRA supports a multi-disciplinary and inter-professional approach to continuing education and patient care by also providing relevant education for other healthcare professionals not directly engaging in interventional regional anesthesia and/or pain medicine procedures. ASRA offers learning opportunities to the national and international healthcare community. 

Accreditation and credit designation statements

Credits by Day

Maximum

Thursday

8.25

Friday

8.50

Saturday

7.00

Total Credits:

23.75

Physicians: The American Society of Regional Anesthesia and Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  

The American Society of Regional Anesthesia and Pain Medicine designates this live activity for a maximum of 23.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

PAs (Physicians Assistants): AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 23.75 hours of Category 1 credit for completing this program. 

Nurse Practitioners: The American Association of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. This activity has been approved for a maximum of 23.75 AMA PRA Category 1 Credits™. 

Registered Nurses: Regulations dictate that only physicians may earn CME credits, however, many state Boards of Registered Nursing accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. Attendees are responsible for confirming their specific board’s acceptance of ASRA-provided credits. This activity has been approved for a maximum of 23.75 AMA PRA Category 1 Credits™. 

The American Board of Anesthesiology® MOCA®

Part 2 Patient Safety CME: This activity contributes to the patient safety CME requirement for the CME component of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in AnesthesiologyTM program (MOCA®), known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements. Max. 13.75 credits. 

Thursday (max. 6.50 credits)

  • 8:15 am, Refresher Course, A Brave New World: Novel Opioid Targets (1.50 credits)
  • 10:00 am, Refresher Course, The Intersection of Alcohol Use and Chronic Pain (2.00 credits)
  • 12:15 pm, PBLD-07, Malfunctioning Baclofen Intrathecal Pumps: Managing This Potentially Deadly Complication (1.00 credit)
  • 12:15 pm, PBLD-10, Tweet Tweet: How Social Media Can Transform Medical Education and Patient Safety (1.00 credit)
  • 12:15 pm, PBLD-12, Logistics and Experiences with Inpatient Lidocaine and Ketamine Infusions for Acute and Chronic Pain Conditions (1.00 credit)
  • 12:15 pm, PBLD-14, Prescribing Opioids for the Patient Using (Legal or Medicinal) Marijuana: Is It Safe? Are you Safe? (1.00 credit)
  • 12:15 pm, PBLD-17, DRG Stimulation: Clinical Pearls Related to Trial and Implantation (1.00 credit)
  • 1:30 pm, IS-03, Risk Mitigation and Complication Management for the Interventional Pain Practitioner (2.00 credits) 

Friday (max. 5.25 credits)

  • 8:00 am, PS-01a, Buprenorphine: It’s Not What We Thought It Was (1.75 credits)
  • 8:00 am, PS-01b, Not Forever Young: The Impact and Importance of Treating Pediatric Pain (1.75 credits)
  • 1:45 pm, PS-03b, Addiction in Pain Medicine: It’s Not Just About Opioids (1.75 credits)
  • 1:45 pm, IS-07, Intrathecal Drug Delivery: Optimal Management of Patients with Pain and/or Spasticity (1.75 credits)
  • 4:15 pm, IS-08, Cannabis and Cannabinoids in Pain Medicine (1.75 credits) 

Saturday (max. 2.00 credits)

  • 10:45 am, Plen-02, Primum Non Nocere: It Goes Both Ways (2.00 credits) 

Credit Reporting to the ABA: ASRA is an ABA-approved provider and, as a service to ASRA members and participants, CME credits are reported to the ABA. Participants must include their correctly formatted ABA ID number (34567890) during the online evaluation and credit claim process available at the conclusion of the activity. Once the online evaluation and credit claim process is closed, certificates will be issued and credits reported to the ABA. After this time, participants may request their CME certificate by contacting asrameetings@asra.com, but ASRA will no longer report credits to the ABA, which will then be the individual participant’s responsibility. Maintenance of Certification in AnesthesiologyTM program and MOCA® are registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of The American Board of Anesthesiology®

ASRA-ASA Ultrasound-Guided Regional Anesthesia (UGRA) Education and Clinical Training Portfolio

The Ultrasound-Guided Regional Anesthesia Education and Clinical Training Portfolio is a joint ASRA - ASA initiative designed for anesthesiologists who wish to distinguish themselves in the field and provide evidence of training and experience.  The portfolio guides participants through a comprehensive educational and training experience that fulfills current recommendations for ultrasound-guided regional anesthesia (UGRA). This ASRA course has been approved for knowledge base and technical skills components of the portfolio. For more information and approved sessions, visit the ASA website. 

International credits

Royal College of Physicians and Surgeons of Canada: The Royal College of Physicians and Surgeons of Canada has agreements based on the mutual recognition of credit points with the American Medical Association for live and web-based (synchronous or asynchronous) educational events.  You may submit your CME certificate directly for credit recognition of this accredited group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca 

European Accreditation Council for Continuing Medical Education (UEMS-EACCME): The UEMS-EACCME has agreements based on the mutual recognition of credit points with the American Medical Association for live and e-learning educational events.  Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net

Commercial support disclosure

Click here to view all industry support (coming soon). This course is supported, in part, by educational grants and in-kind support from industry. All support is managed in strict accordance with the ACCME’s Standards for Commercial Support. Appropriate acknowledgement of all supporting organizations is made to participants prior to the educational activity in the program guide, on the event website, and with signage during the meeting.  View the guidelines for company representative and in-kind support.  

Disclosure and resolution of personal conflicts of interest

Click here to view all faculty disclosure (coming soon). In accordance with the ACCME’s Standards for Commercial Support and related policies, ASRA is committed to ensuring balance, independence, objectivity, and scientific rigor in its CME/CPD activities. Those in control of the educational content disclose all relevant relationships (financial or other) with any commercial interest that they or their spouse/partner have had within the past 12 months. If an individual refuses to disclose, they are disqualified from participating. Disclosure information is evaluated and conflicts of interest resolved. Disclosure is made to participants prior to the activity. Participants are asked to evaluate the objectivity and independence. Off-label or investigational use of a therapeutic product is also disclosed.